Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
ItalyStudy on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications
ItalyStudy on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia
ItalyStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
ItalyStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
ItalyPhase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy
ItalyStudy on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis
ItalyStudy of Pembrolizumab and Drug Combination for Patients with Advanced Esophageal Cancer
ItalyEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ItalyStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
ItalyStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
